The Role of MGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators As Novel Therapeutic Strategies

Overview

Journal Curr Neuropharmacol

Publisher Bentham Science Publishers

Date 2016 Jun 15

PMID 27296640

Citations 8

Authors

Rebecca K Senter

Ayan Ghoshal

Adam G Walker

Zixiu Xiang

Colleen M Niswender

P Jeffrey Conn

Affiliations

Soon will be listed here.

Abstract

Long-term potentiation (LTP) and long-term depression (LTD) are two distinct forms of synaptic plasticity that have been extensively characterized at the Schaffer collateral-CA1 (SCCA1) synapse and the mossy fiber (MF)-CA3 synapse within the hippocampus, and are postulated to be the molecular underpinning for several cognitive functions. Deficits in LTP and LTD have been implicated in the pathophysiology of several neurological and psychiatric disorders. Therefore, there has been a large effort focused on developing an understanding of the mechanisms underlying these forms of plasticity and novel therapeutic strategies that improve or rescue these plasticity deficits. Among many other targets, the metabotropic glutamate (mGlu) receptors show promise as novel therapeutic candidates for the treatment of these disorders. Among the eight distinct mGlu receptor subtypes (mGlu1-8), the mGlu1,2,3,5,7 subtypes are expressed throughout the hippocampus and have been shown to play important roles in the regulation of synaptic plasticity in this brain area. However, development of therapeutic agents that target these mGlu receptors has been hampered by a lack of subtype-selective compounds. Recently, discovery of allosteric modulators of mGlu receptors has provided novel ligands that are highly selective for individual mGlu receptor subtypes. The mGlu receptors modulate the multiple forms of synaptic plasticity at both SC-CA1 and MF synapses and allosteric modulators of mGlu receptors have emerged as potential therapeutic agents that may rescue plasticity deficits and improve cognitive function in patients suffering from multiple neurological and psychiatric disorders.

Citing Articles

Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators.

Kos J, Langiu M, Hellyer S, Gregory K ACS Pharmacol Transl Sci. 2024; 7(12):3671-3690.

PMID: 39698283 PMC: 11651194. DOI: 10.1021/acsptsci.4c00213.

Loss of mGlu receptors in somatostatin-expressing neurons alters negative emotional states.

Ramos-Prats A, Matulewicz P, Edenhofer M, Wang K, Yeh C, Fajardo-Serrano A Mol Psychiatry. 2024; 29(9):2774-2786.

PMID: 38575807 PMC: 11420089. DOI: 10.1038/s41380-024-02541-5.

The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice.

Ploska A, Siekierzycka A, Cieslik P, Dobrucki L, Kalinowski L, Wieronska J Molecules. 2024; 29(3).

PMID: 38338372 PMC: 10856750. DOI: 10.3390/molecules29030627.

Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors.

McCullock T, Cardani L, Kammermeier P Mol Pharmacol. 2024; 105(2):104-115.

PMID: 38164584 PMC: 10794986. DOI: 10.1124/molpharm.123.000795.

The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Boczek T, Mackiewicz J, Sobolczyk M, Wawrzyniak J, Lisek M, Ferenc B Cells. 2021; 10(5).

PMID: 34067760 PMC: 8155952. DOI: 10.3390/cells10051228.

References

Contractor A, Swanson G, Heinemann S . Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron. 2001; 29(1):209-16. DOI: 10.1016/s0896-6273(01)00191-x. View

Genazzani A, Casabona G, Lepiscopo M, Condorelli D, DellAlbani P, Shinozaki H . Characterization of metabotropic glutamate receptors negatively linked to adenylyl cyclase in brain slices. Brain Res. 1993; 622(1-2):132-8. DOI: 10.1016/0006-8993(93)90811-z. View

Lu Y, Jia Z, Janus C, Henderson J, Gerlai R, Wojtowicz J . Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci. 1997; 17(13):5196-205. PMC: 6573299. View

Bradley S, Levey A, Hersch S, Conn P . Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies. J Neurosci. 1996; 16(6):2044-56. PMC: 6578504. View

Francesconi W, Cammalleri M, Sanna P . The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region. Brain Res. 2004; 1022(1-2):12-8. DOI: 10.1016/j.brainres.2004.06.060. View

Salin P, Scanziani M, Malenka R, Nicoll R . Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc Natl Acad Sci U S A. 1996; 93(23):13304-9. PMC: 24088. DOI: 10.1073/pnas.93.23.13304. View

Huber K, Roder J, Bear M . Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. J Neurophysiol. 2001; 86(1):321-5. DOI: 10.1152/jn.2001.86.1.321. View

Gereau 4th R, Conn P . Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. J Neurophysiol. 1995; 74(1):122-9. DOI: 10.1152/jn.1995.74.1.122. View

Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I . A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. FASEB J. 2012; 26(4):1682-93. DOI: 10.1096/fj.11-195941. View

10.

Snyder E, Philpot B, Huber K, Dong X, Fallon J, Bear M . Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat Neurosci. 2001; 4(11):1079-85. DOI: 10.1038/nn746. View

11.

Zalutsky R, Nicoll R . Comparison of two forms of long-term potentiation in single hippocampal neurons. Science. 1990; 248(4963):1619-24. DOI: 10.1126/science.2114039. View

12.

Uyama Y, Ishida M, Shinozaki H . DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice. Brain Res. 1997; 752(1-2):327-30. DOI: 10.1016/s0006-8993(97)00079-6. View

13.

Malinow R, Miller J . Postsynaptic hyperpolarization during conditioning reversibly blocks induction of long-term potentiation. Nature. 1986; 320(6062):529-30. DOI: 10.1038/320529a0. View

14.

Kwon H, Castillo P . Long-term potentiation selectively expressed by NMDA receptors at hippocampal mossy fiber synapses. Neuron. 2008; 57(1):108-20. PMC: 2390917. DOI: 10.1016/j.neuron.2007.11.024. View

15.

Okamoto N, Hori S, Akazawa C, Hayashi Y, Shigemoto R, Mizuno N . Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J Biol Chem. 1994; 269(2):1231-6. View

16.

Yokoi M, Kobayashi K, Manabe T, Takahashi T, Sakaguchi I, Katsuura G . Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science. 1996; 273(5275):645-7. DOI: 10.1126/science.273.5275.645. View

17.

Gereau 4th R, Winder D, Conn P . Pharmacological differentiation of the effects of co-activation of beta-adrenergic and metabotropic glutamate receptors in rat hippocampus. Neurosci Lett. 1995; 186(2-3):119-22. DOI: 10.1016/0304-3940(95)11300-l. View

18.

Varnes J, Marcus A, Mauger R, Throner S, Hoesch V, King M . Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Bioorg Med Chem Lett. 2011; 21(5):1402-6. DOI: 10.1016/j.bmcl.2011.01.027. View

19.

Henze D, Urban N, Barrionuevo G . The multifarious hippocampal mossy fiber pathway: a review. Neuroscience. 2000; 98(3):407-27. DOI: 10.1016/s0306-4522(00)00146-9. View

20.

Watanabe M, Fukaya M, Sakimura K, Manabe T, Mishina M, Inoue Y . Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fibre-recipient layer) of the mouse hippocampal CA3 subfield. Eur J Neurosci. 1998; 10(2):478-87. DOI: 10.1046/j.1460-9568.1998.00063.x. View